Isolation of DNA molecules using mer- capto-aryl ligands

Details for Australian Patent Application No. 2002302534 (hide)

Owner GE Healthcare Bio-Sciences AB

Inventors Stadler, Joachim; Nyhammar, Tomas; Berglof, Jan; Lemmens, Raf

Agent Davies Collison Cave

Pub. Number AU-B-2002302534

PCT Number PCT/EP02/04152

PCT Pub. Number WO2002/083893

Priority 0103436.2 12.10.01 SE; 0101380.4 18.04.01 SE

Filing date 15 April 2002

Wipo publication date 28 October 2002

Acceptance publication date 20 September 2007

International Classifications

G01N 30/06 (2006.01) Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

B01J 20/281 (2006.01) Solid sorbent compositions - Sorbents specially adapted for preparative, analytical or investigative chromatography

B01J 20/283 (2006.01) Solid sorbent compositions

B01J 20/285 (2006.01) Solid sorbent compositions

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 30/26 (2006.01) Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

G01N 30/50 (2006.01) Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

G01N 30/80 (2006.01) Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

G01N 30/88 (2006.01) Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 0103436.2 12.10.01 SE; 0101380.4 18.04.01 SE

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002302534

9 March 2006 Change of Name(s) of Applicant(s), Section 104

  Amersham Biosciences AB The name of the applicant has been changed to GE Healthcare Bio-Sciences AB

20 September 2007 Application Accepted

  Published as AU-B-2002302534

17 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002302535-HUMAN CELLULAR PROTEIN GASTROINTESTINAL GLUTATHIONE PEROXIDASE AS TARGET FOR MEDICAL INTERVENTION AGAINST HEPATITIS C VIRUS INFECTIONS

2002302533-FCC reactor vessel